1. Signaling Pathways
  2. Metabolic Enzyme/Protease
  3. Cytochrome P450

Cytochrome P450

P450

CYPs

Cytochrome p450 comprises a superfamily of heme-thiolate proteins named for the spectral absorbance peak of their carbon-monoxide-bound species at 450 nm. Having been found in every class of organism, including Archaea, the p450 superfamily is believed to have originated from an ancestral gene that existed over 3 billion years ago. Repeated gene duplications have subsequently given rise to one of the largest of multigene families. These enzymes are notable both for the diversity of reactions that they catalyze and the range of chemically dissimilar substrates upon which they act. Cytochrome p450s support the oxidative, peroxidative and reductive metabolism of such endogenous and xenobiotic substrates as environmental pollutants, agrochemicals, plant allelochemicals, steroids, prostaglandins and fatty acids. In humans, Cytochrome p450s are best known for their central role in phase I drug metabolism where they are of critical importance to two of the most significant problems in clinical pharmacology: drug interactions and interindividual variability in drug metabolism.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-U00373
    Revexepride
    Activator 99.84%
    Revexepride is a highly selective 5-HT4 receptor agonist, and a potential inducer of CYP3A4 enzyme, used for the treatment of gastroesophageal reflux disease.
    Revexepride
  • HY-119647
    PPOH
    Inhibitor 99.87%
    PPOH, a fatty acid derivative, is a selective cyclooxygenase (COX) inhibitor that inhibits arachidonic acid cyclooxygenase activity in renal cortical microsomes. In addition, PPOH acts on CYP4A2 and CYP4A3 with the IC50 values of 22 μM and 6.5 μM, respectively. PPOH is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
    PPOH
  • HY-N0292R
    Oleuropein (Standard)
    Inhibitor
    Oleuropein (Standard) is the analytical standard of Oleuropein. This product is intended for research and analytical applications. Oleuropein, found in olive leaves and oil, exerts antioxidant, anti-inflammatory and anti-atherogenic effects through direct inhibition of PPARγ transcriptional activity. Oleuropein induces apoptosis in breast cancer cells via the p53-dependent pathway and through the regulation of Bax and Bcl2 genes. Oleuropein also inhibits aromatase.
    Oleuropein (Standard)
  • HY-125598
    Secologanin
    Secologanin, a secoiridoid glucoside, is a pivotal terpenoid intermediate in the biosynthesis of biologically active monoterpenoid indole alkaloids such as reserpine, ajmaline, and vinblastine. Secologanin synthase (cytochrome P450 isoform CYP72A1) catalyzes the oxidative cleavage of loganin into Secologanin.
    Secologanin
  • HY-W458364
    1-(Isothiazol-3-yl)ethan-1-one
    Inhibitor
    1-(Isothiazol-3-yl)ethan-1-one (Q11) is a CYP2E1 inhibitor. 1-(Isothiazol-3-yl)ethan-1-one can be used in rheumatoid arthritis and sepsis related research.
    1-(Isothiazol-3-yl)ethan-1-one
  • HY-128369
    Acid Yellow 36
    Inducer
    Acid Yellow 36 (Metanil Yellow) is an azo dye and a pH indicator. Acid Yellow 36 changes its color from red at pH 1.2 to yellow at pH 2.3. Acid Yellow 36 is used in the leather, paper and textile industries. Acid Yellow 36 acts as a bifunctional inducer of specific isozymes of P-450 and cytosolic enzymes.
    Acid Yellow 36
  • HY-17514S2
    Itraconazole-d9
    Itraconazole-d9 is the deuterium labeled Itraconazole[1]. Itraconazole (R51211) is a triazole antifungal agent and a potent and orally active Hedgehog (Hh) signaling pathway antagonist with an IC50 of ~800 nM. Itraconazole potently inhibits lanosterol 14α-demethylase (cytochrome P450 enzyme), thereby inhibits the oxidative conversion of lanosterol to ergosterol. Itraconazole has anticancer and antiangiogenic effects. Itraconazole is a oxysterol-binding protein (OSBP) inhibitor[2][3][4][5].
    Itraconazole-d<sub>9</sub>
  • HY-116862
    Dibenzylfluorescein
    99.54%
    Dibenzylfluorescein (DBF) is a fluorogenic probe (Fluoresecent dye) that acts as a substrate for specific cytochrome P450 (CYP) isoforms, including CYP3A4, CYP2C8, CYP2C9, CYP2C19, and aromatase (CYP19). Dibenzylfluorescein is typically used near its Km value of 0.87-1.9 µM (Ex=485nm,Em=535nm). Dibenzylfluorescein is used to detect changes in CYP catalytic activity caused by drugs or disease.
    Dibenzylfluorescein
  • HY-130419
    (±)13(14)-EpDPA
    (±)13(14)-EpDPA (13,14-EpDPE) is the product of the reaction of cytochrome P-450 epoxygenase with Docosahexaenoic Acid (DHA).(±)13(14)-EpDPA has antihyperalgesic and vasorelaxative activities.
    (±)13(14)-EpDPA
  • HY-112734
    4'-Methylchrysoeriol
    Inhibitor 99.17%
    4'-Methylchrysoeriol is a potent inhibitor of Cytochrome P450 enzymes, with an IC50 of 19 nM for human P450 1B1-dependent EROD.
    4'-Methylchrysoeriol
  • HY-121580
    Tabimorelin
    Inhibitor
    Tabimorelin (NN703) is an orally active growth hormone (GH) secretagogue. Tabimorelin is also a potent inhibitor of CYP3A4 activity.
    Tabimorelin
  • HY-W019847
    Azamulin
    Inhibitor
    Azamulin is an irreversible, highly selective inhibitior of human CYP3Aa. Azamulin has CYP3A inhibition activity with IC50 values range from 0.03-0.24 μM. Azamulin can be used for the research of metabolism and antiinfection.
    Azamulin
  • HY-N1201S
    Apigenin-d5
    Inhibitor 98.90%
    Apigenin-d5 is a deuterated labeled Apigenin. Apigenin (4',5,7-Trihydroxyflavone) is a competitive CYP2C9 inhibitor with a Ki of 2 μM.
    Apigenin-d<sub>5</sub>
  • HY-D0144
    Resorufin methyl ether
    99.75%
    Resorufin methyl ether (Methoxyresorufin) is a cytochrome P450 fluorometric substrate. Resorufin methyl ether is a relatively specific substrate for CYP1A2 activity in rodents.
    Resorufin methyl ether
  • HY-B1462R
    Chlorzoxazone (Standard)
    Modulator 99.81%
    Chlorzoxazone (Standard) is the analytical standard of Chlorzoxazone. This product is intended for research and analytical applications.
    Chlorzoxazone (Standard)
  • HY-N1993
    5-Methyl-7-methoxyisoflavone
    Inhibitor 99.78%
    5-Methyl-7-methoxyisoflavone is an orally active anti-oxidant with remyelinating activity. 5-Methyl-7-methoxyisoflavone inhibits the enzyme aromatase, interfering with the normal metabolic pathways of testosterone. 5-Methyl-7-methoxyisoflavone is a non-steroidal anabolic isoflavone, used as a anabolic agent. 5-Methyl-7-methoxyisoflavone shows better potency increasing muscle mass and endurance than Ipriflavone (HY-N0094). 5-Methyl-7-methoxyisoflavone can be used for fat loss besides the maintenance of low cholesterol level and strengthen bones. 5-Methyl-7-methoxyisoflavone is the inhibitor for NF-κB.
    5-Methyl-7-methoxyisoflavone
  • HY-111202
    Pyributicarb
    Activator 99.94%
    Pyributicarb, a carbamate-type herbicide, is a potent activator of both CYP3A4 gene and human pregnane X receptor (hPXR).
    Pyributicarb
  • HY-120648A
    CAY 10462 dihydrochloride
    Inhibitor 98.02%
    CAY 10434 dihydrochloride is a potent CYP4A hydroxylase inhibitor. CAY 10434 dihydrochloride improves contractile response to angiotensin II with the maximal contractile response (Emax) 6764 mg.
    CAY 10462 dihydrochloride
  • HY-N1882
    4,5-Dimethoxycanthin-6-one
    Inhibitor 98.68%
    4,5-Dimethoxycanthin-6-one is a potent and uncompetitive inhibitor of CYP1A2-mediated phenacetin O-deethylation with an IC50 value of 1.7μM and a Ki value of 2.6 μM. 4,5-Dimethoxycanthin-6-one, as an alkaloid, is isolated from the wood of Picrasma quassioides BENNET (Simaroubaceae).
    4,5-Dimethoxycanthin-6-one
  • HY-113031
    16a-Hydroxydehydroisoandrosterone
    98.40%
    16a-Hydroxydehydroisoandrosterone (16α-Hydroxy-DHEA) is a metabolite of the endogenous steroid hormone dehydroepiandrosterone. 16α-hydroxy Dehydroepiandrosterone is formed from dehydroepiandrosterone via 16-hydroxylation by the cytochrome P450 (CYP) isoforms CYP3A4 and CYP3A5 in adult human liver microsomes, as well as by fetal recombinant CYP3A7. It is a precursor to fetal estrogens, including estriol.
    16a-Hydroxydehydroisoandrosterone
Cat. No. Product Name / Synonyms Application Reactivity

CYP1

CYP2

CYP3

CYP4

CYP11

CYP17

Aromatase/CYP19A1

CYP26

CYP51

CYP1A2

CYP2D6

CYP2C9

CYP2C19

CYP3A4

CYP17A1

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

Cytochrome P450 Inducers, Degraders, Inhibitors, Activators & Modulators
Product NameCYP1CYP2CYP3CYP4CYP11CYP17Aromatase/CYP19A1CYP26CYP51CYP1A2CYP2D6CYP2C9CYP2C19CYP3A4CYP17A1Purity    
Verapamil  
CYP3
            99.96%
Fenofibrate 
CYP2C19, IC50: 0.2 μM
CYP2B6, IC50: 0.7 μM
CYP2C9, IC50: 9.7 μM
CYP2C8, IC50: 4.8 μM
CYP3A4, IC50: 142.1 μM
            99.97%
Apigenin 
CYP2
             99.22%
Verapamil hydrochloride  
CYP3
            99.98%
Aminoglutethimide      
Aromatase
        98.79%
Letrozole      
Aromatase
        99.95%
Ketoconazole  
CYP3
CYP4
           99.51%
Abiraterone     
CYP17
         99.88%
1-Aminobenzotriazole 
CYP2
CYP3
            99.88%
Abiraterone acetate     
CYP17
         99.96%
Clarithromycin  
CYP3
            99.90%
Stiripentol 
CYP2
CYP3
            99.99%
Cepharanthine 
CYP2E1, IC50: 25.62 μM
CYP2C9, IC50: 24.57 μM
CYP3A4, IC50: 16.29 μM
            99.91%
Diosmetin
CYP1
              99.63%
Gemfibrozil 1-O-β-glucuronide 
CYP2C8, IC50: 4.07 μM
             99.88%
Salvianolic acid C 
CYP2C8, Ki: 4.82 μM
CYP2J2, Ki: 5.75 μM
             99.94%
Fomepizole 
CYP2E1
             99.67%
Oleuropein      
Aromatase
        99.05%
Talarozole       
CYP26
       99.61%
HET0016   
CYP4
           99.69%
Anastrozole      
Aromatase
        99.99%
(S)-Mephenytoin 
CYP2
             99.85%
Galangin
CYP1
              99.96%
Sulfaphenazole 
CYP2C9
             99.85%
Cobicistat  
CYP3
            99.77%
Gemfibrozil
CYP1A2, Ki: 82 μM
CYP2C9, Ki: 5.8 μM
CYP2C19, Ki: 24 μM
CYP2C8, Ki: 69 μM
             99.91%
Troleandomycin  
CYP3
            ≥98.0%
Exemestane      
Aromatase
        99.83%
Clobetasol propionate  
CYP3A5, IC50: 0.206 μM
CYP3A4, IC50: 15.6 μM
            99.85%
Schisandrin A  
CYP3A, IC50: 6.6 μM
            99.89%
Clopidogrel hydrogen sulfate 
CYP2B6, IC50: 18.2 nM
CYP2C19, IC50: 524 nM
             99.43%
Bergamottin
CYP1A1, Ki: 10.703 nM
CYP1A1, IC50: 0.192 μM
CYP1A2, IC50: 5.077 μM
CYP2B2, IC50: 4.535 μM
CYP2B1, IC50: 9.495 μM
             99.80%
Isavuconazole  
CYP3
            99.99%
Ginsenoside C-K 
CYP2C9, IC50: 32 μM
CYP2A6, IC50: 63.6 μM
             99.92%
Gentiopicroside 
CYP2
             99.83%
TMS
CYP1B1, IC50: 6 nM
CYP1A1, IC50: 300 nM
CYP1A2, IC50: 3.1 μM
CYP1B1, Ki: 3 nM
              98.61%
Alpha-Naphthoflavone      
Aromatase
        98.54%
K777  
CYP3
            99.77%
Pregnenolone 16α-carbonitrile 
CYP2
CYP3
            98.48%
AS1810722  
CYP3A4
            98.14%
Ginsenoside Rd
CYP1A2, IC50: 78.4 μM
CYP2D6, IC50: 58 μM
CYP2C9, IC50: 85.1 μM
CYP3A4, IC50: 81.7 μM
            99.88%
Olivetol 
CYP2
             99.81%
Tetrahydrocurcumin 
CYP2C9
CYP3A4
            98.96%
7-Ethoxyresorufin
CYP1
              99.61%
Phillyrin
CYP1
CYP2
             98.99%
Topiroxostat  
CYP3
            99.06%
Rhapontigenin
CYP1A1, IC50: 400 nM
              99.66%
Atazanavir  
CYP3
            99.86%
Dronedarone  
CYP3
            99.93%
Clomethiazole 
CYP2
             98.65%
Galeterone     
CYP17
         99.87%
BMS-986202 
CYP2C19, IC50: 14 μM
             99.92%
Endoxifen hydrochloride      
Aromatase
        98.75%
Atazanavir sulfate  
CYP3
            99.94%
Ranitidine hydrochloride 
CYP2
             99.88%
Mephenytoin 
CYP2
             99.96%
CYP3cide  
CYP3A4, EC50: 30 nM
CYP3A5, EC50: 17 μM
CYP3A7, EC50: 71 μM
            99.92%
Curcumenol  
CYP3
            99.98%
Schisandrol B 
CYP2
CYP3A
            99.99%
Ticlopidine 
CYP2
CYP3
            99.56%
Tebuconazole        
CYP51
      99.66%
Bergaptol  
CYP3
            99.44%
5,7-Dimethoxyflavone  
CYP3A
            99.86%
Chlorzoxazone 
CYP2
             99.84%
Endoxifen      
Aromatase
        99.42%
Utreloxastat         
CYP1A2, IC50: > 5.3 μM
     99.69%
Fadrozole hydrochloride      
Aromatase
        99.91%
Oteseconazole           
CYP2C9, IC50: 99 μM
CYP2C19, IC50: 72 μM
  99.46%
Cecropin B  
CYP3
            99.00%
LKY-047 
CYP2J2, IC50: 1.7 μM
             99.94%
Dihydromethysticin  
CYP3
            99.94%
Casopitant mesylate  
CYP3A4
            99.84%
(S)-(+)-N-3-Benzylnirvanol            
CYP2C19, Ki: 250 nM
  99.82%
Cedrol 
CYP2
CYP3
            99.76%
APD668 
CYP2C9, Ki: 0.1 μM
             99.73%
Fadrozole      
Aromatase
        99.78%
Columbamine chloride             
CYP3A4, IC50: 30.6 μM
 98.63%
Obtusifoliol        
CYP51
      99.86%
Isosilybin  
CYP3
            99.95%
Harmalol hydrochloride
CYP1
              99.72%
Fipronil
CYP1
CYP2
CYP3
            98.98%
Oxiconazole nitrate  
CYP3A4
            ≥98.0%
Ginsenoside F1 
CYP2
CYP3A4
            ≥99.0%
AZD7325
CYP1A2
 
CYP3A4
            99.71%
Seviteronel     
CYP17
         99.83%
Cephaeline dihydrochloride 
CYP2
             99.84%
6',7'-Dihydroxybergamottin  
CYP3A4
            ≥99.0%
β-​Apo-​8'-​carotenal
CYP1A1
CYP1A2
              
Ranitidine 
CYP2C19
CYP2C9
             ≥99.0%
Liarozole       
CYP26, IC50: 7 μM
       98.83%
Friedelin 
CYP2
CYP3
            ≥99.0%
Flavanone      
Aromatase
        99.84%
Dihydrolanosterol        
CYP51
      99.56%
TP0472993   
CYP4A11, IC50: 140 nM
CYP4F2, IC50: 40 nM
           98.69%
Ezutromid
CYP1
              98.10%
PC945        
CYP51A, IC50: 0.23 μM
CYP51B, IC50: 0.22 μM
      99.27%
AMG-208  
CYP3A4, IC50: 32 μM
            99.86%
Tetrahydropiperine
CYP1A1, IC50: 23 μM
              99.41%
Nicotelline       
CYP26, Ki: ≥300 μM
       99.92%
MS-PPOH 
CYP2
             99.27%
Mefentrifluconazole        
CYP51A, Kd: 0.5 nM
      99.61%
2-Phenyl-2-(1-piperidinyl)propane
CYP1A2, IC50: >300 μM
CYP2B6, IC50: 5.1 μM
CYP2B6, Ki: 5.6 μM
CYP2D6, IC50: 74 μM
CYP2A6, IC50: >300 μM
CYP2C8, IC50: >300 μM
CYP2C9, EC50: >300 μM
CYP2C19, IC50: >300 μM
CYP2E1, IC50: >300 μM
CYP3A, IC50: 200 μM
            99.81%
Dagrocorat 
CYP2D6
CYP3A
            99.90%
(R)-(+)-Aminoglutethimide      
Aromatase
        
Columbamine             
CYP3A4, IC50: 30.6 μM
 99.70%
NN1177 TFA             
CYP3A4
 98.66%
Carbosulfan
CYP1
CYP2
CYP3
            ≥98.0%
Orteronel     
CYP17
         99.70%
Dapaconazole       
CYP26, IC50: 1.4 μM
       99.76%
Quilseconazole        
CYP51
      98.98%
N-Nornuciferine 
CYP2
             99.94%
Linderane 
CYP2
             99.61%
IDO1-IN-19 
CYP2C9, IC50: 8.64 μM
             98.52%
Chrysosplenetin  
CYP3A
            99.68%
Fenofibrate (Standard) 
CYP2B6
CYP2C19
CYP2C8
CYP2C9
CYP3A4
            99.91%
2,6-Dimethylquinoline
CYP1A2, IC50: 3.3 μM
CYP2B6, IC50: 480 μM
             99.95%
ACP-5862 
CYP2C8
CYP3A4
            98.41%
DMU2105
CYP1B1, IC50: 10 nM
CYP1A1, IC50: 742 nM
              99.54%
BI 689648    
CYP11
          99.20%
Nampt-IN-5  
CYP3, IC50: 0.7 nM
            98.02%
Phortress
CYP1
              99.25%
α-​Terpinyl acetate 
CYP2B6, Kd: 5.4  μM
             
ML252
CYP1A2, IC50: 6.1 μM
CYP2C9, IC50: 18.9 μM
CYP2D6, IC50: 19.9 μM
CYP3A4, IC50: 3.9 μM
            99.9%
CYP19A1-IN-2      
Aromatase
        98.88%
Antihistamine-1 
CYP2D6, IC50: 5.4 μM
             99.45%
D4-abiraterone     
CYP17
         99.75%
CYP1B1-IN-4
CYP1B1, IC50: 0.2 nM
CYP1A1, IC50: 3.98 μM
              99.09%
Liarozole dihydrochloride       
CYP26, IC50: 7 μM
       ≥99.0%
Polygalaxanthone III 
CYP2
             99.76%
ONT-993 
CYP2D6, IC50: 7.9 μM
             99.85%
BI 653048
CYP1A2, IC50: 50 μM
CYP2D6, IC50: 41 μM
CYP2C9, IC50: 12 μM
CYP2C19, IC50: 9 μM
CYP3A4, IC50: 8 μM
            99.84%
DMU2139
CYP1B1, IC50: 9 nM
CYP1A1, IC50: 795 nM
              ≥98.0%
Fomepizole hydrochloride 
CYP2E1
             99.85%
Pradefovir mesylate  
CYP3
            99.89%
Exemestane (Standard)      
Aromatase
        99.63%
Abiraterone acetate (Standard)     
CYP17
         99.85%
8-Geranyloxypsoralen  
CYP3
            99.93%
SDZ285428        
CYP51
      98.00%
Dagrocorat hydrochloride 
CYP2D6
CYP3A
            99.85%
CYP4A11/CYP4F2-IN-1   
CYP4A11, IC50: 19 nM
CYP4F2, IC50: 17 nM
           99.82%
SR9186  
CYP3
            98.06%
Seviteronel (R enantiomer)     
CYP17
         98.82%
Letrozole-d4      
Aromatase
        99.82%
Abiraterone decanoate     
CYP17
         99.69%
BMS-819881  
CYP3A4, EC50: 13 μM
            
hCYP3A4 Fluorogenic substrate 1  
CYP3A4, Km: 0.36 μM
            99.27%
MCH-1 antagonist 1  
CYP3A4, IC50: 10 μM
            
1'-Hydroxy bufuralol 
CYP2
             
Eriodictyol chalcone      
Aromatase
        
ε-​Viniferin
CYP1A2, Ki: 5 μM ((EROD))
CYP2B6, Ki: 3 μM ((BROD))
CYP2A6, Ki: 60 μM ((COH))
CYP2E1, IC50: 25 μM ((CHZ))
CYP3A4, Ki: 10 μM ((TST))
CYP4A, IC50: 15 μM ((LwOH))
           ≥98.0%
Gemfibrozil (Standard)
CYP1A2
CYP2C19
CYP2C8
CYP2C9
             99.90%
CYP11B2-IN-1    
CYP11B2, IC50: 2.3 nM
CYP11B1, IC50: 142 nM
          99.83%
Revexepride  
CYP3A4
            99.84%
1-(Isothiazol-3-yl)ethan-1-one 
CYP2E1
             
Tabimorelin  
CYP3A4
            
Azamulin  
CYP3A, IC50: 0.03-0.24 μM
            
Resorufin methyl ether
CYP1
              99.75%
Chlorzoxazone (Standard) 
CYP2
             99.81%
4,5-Dimethoxycanthin-6-one
CYP1A2, IC50: 1.7 μM
CYP1A2, Ki: 2.6 μM
              98.68%
Vorozole      
Aromatase
        
ODM-204     
CYP17
         
IHMT-PI3Kδ-372 
CYP2C9, IC50: 2.7 μM
             
BMS-986339 
CYP2C8, IC50: 8 μM
CYP2C9, IC50: 13.5 μM
             
Fadrozole hydrochloride hemihydrate      
Aromatase
        
Anastrozole-d12      
Aromatase
        
Endoxifen-d5      
Aromatase
        
CYP3A4-IN-2  
CYP3A4, IC50: 0.055 μM
            
Clarithromycin (Standard)  
CYP3
            
CYP11B1-IN-2
CYP1A2, IC50: >10 μM
CYP2C9, IC50: >10 μM
CYP2C19, IC50: >10 μM
CYP2D6, IC50: >10 μM
CYP2E1, IC50: >10 μM
CYP3A4, IC50: >10 μM
 
CYP11B1, IC50: 9 ± 2 nM (human CYP11B1)
CYP11B1, IC50: 25 nM (rat CYP11B1)
CYP11B2, IC50: 1121 ± 237 nM
          
Antitumor agent-88
CYP1A1, Ki: 1.4 μM
              
17-HETE
CYP1B1
              
SYN20028567      
Aromatase
        
P-gp inhibitor 23             
CYP3A4
 
CYP4Z1-IN-1 
CYP2D6, IC50: >10 000 nM
CYP2C9, IC50: >10 000 nM
CYP3A4, IC50: >10 000 nM
CYP4Z1, IC50: 41.8 ± 1.4 nM
CYP4F11, IC50: 291.3 ± 46 nM
CYP4F12, IC50: 1598.3 ± 5 nM
           
CYP3A4-IN-3  
CYP3A4, IC50: 0.075 μM
            
Diosmetin (Standard)
CYP1
              
CYP1B1-IN-2
CYP1B1, IC50: 0.52 nM
CYP1A1, IC50: 16.7 nM
CYP1A2, IC50: 94.2 nM
              
ERα degrader 9      
Aromatase
        
Ginsenoside C-K (Standard) 
CYP2A6
CYP2C9
             
CYP17-IN-1     
CYP17
         
FGFRs-IN-1         
CYP1A2, IC50: 26.33 μM
CYP2D6, IC50: 9.27 μM
 
CYP2C19, IC50: 11.46 μM
  
CYP1B1-IN-5
CYP1B1, IC50: 4.7 nM
CYP1A1, IC50: 190.7 nM
CYP1A2, IC50: 585.7 nM
              
FGFR-IN-10 
CYP2C9, IC50: 3.33 μM
CYP2C19, IC50: 18.75 μM
CYP2D6, IC50: 4.34 μM
CYP3A4, IC50: 0.69 μM
            
CYP17A1/HDAC6-IN-1              
CYP17A1, IC50: 0.284 μM
hCYP1B1-IN-2
CYP1B1, IC50: 0.040 nM
CYP1A1, IC50: 0.38 nM
              
Ginsenoside Rd (Standard)
CYP1A2
CYP2C9
CYP2D6
CYP3A4
            
Antiproliferative agent-53-d3 
CYP2C19, IC50: 0.77 μM
CYP2C9, IC50: 3.1 μM
CYP2D6, IC50: 17.3 μM
CYP3A4, IC50: 14.6 μM
            
CYP17A1-IN-1     
CYP17, IC50: 26 nM
         
HIV-1 inhibitor-40 
CYP2C9, IC50: 5.16 μM
CYP2C19, IC50: 4.51 μM
             
BChE-IN-33 
CYP2C19
CYP2C9
CYP2D6
             
ASN-001              
CYP17A1
Anticancer agent 78      
Aromatase
        
CYP3A4-IN-1  
CYP3A4, IC50: 0.085 μM
            
CYP51/HDAC-IN-1        
CYP51
      
Exemestane-13C3      
Aromatase
        
Kushenol K  
CYP3A4, Ki: 1.35 μM
            
N-Desmethyl diltiazem hydrochloride  
CYP3A7
            
EGFR-IN-137      
Aromatase, IC50: 4.01 μM
        
PROTAC ERα Degrader-9      
Aromatase, IC50: 4.6 μM
        
CYP1B1-IN-3
CYP1B1, IC50: 6.6 nM
CYP1A1, IC50: 347.3 nM
CYP1A2, IC50: >10000 nM
              
Antitumor agent-87
CYP1A1, Ki: 0.23 μM
              
DL-Acetylshikonin
CYP1A2, IC50: 4.0 μM
CYP2A6, IC50: 3.8 μM
CYP2B6, IC50: 2.0 μM
CYP2C8, IC50: 1.4 μM
CYP2C9, IC50: 3.3 μM
CYP2C19, IC50: 2.5 μM
CYP2D6, IC50: 2.5 μM
CYP2E1, IC50: 2.7 μM
CYP2J2, IC50: 3.3 μM
CYP3A, IC50: 2.3 μM
            
Exemestane-d2      
Aromatase
        
5,7,2',6'-Tetrahydroxyflavone  
CYP3A4, IC50: 7.8 μM
            
7-Ethoxy-4-methylcoumarin
CYP1A1
CYP2B6
CYP2B4
             99.44%
Aromatase-IN-3      
Aromatase, IC50: 54 nM
        
YM511      
Aromatase
        99.73%
BI 653048 phosphate
CYP1A2, IC50: 50 μM
CYP2D6, IC50: 41 μM
CYP2C9, IC50: 12 μM
CYP2C19, IC50: 9 μM
CYP3A4, IC50: 8 μM
            
Exemestane-d3      
Aromatase
        
Apigenin (Standard) 
CYP2
             
CFG920    
CYP11B2
CYP17
         
Nav1.7-IN-8 
CYP2C9, IC50: 0.17 μM
CYP3A4, IC50: 0.077 μM
            
Galangin (Standard)
CYP1
              
JNK-IN-14          
CYP2D6, IC50: 26.7 ± 0.5 nM
  
CYP3A4, IC50: 383.0 ± 1. nM
 
Clopidogrel-β-D-glucuronide 
CYP2C8
             
Bucolome 
CYP2
             98.93%
Fenofibrate-d6 
CYP2
CYP3
            99.70%
Oxiconazole  
CYP3A4
            
Tetrahydrocurcumin-d6 
CYP2
CYP3
            
Antibacterial agent 132      
Aromatase
        
1,2,3,6,7,8-Hexachlorodibenzofuran
CYP1A1
              
Androsta-1,4,6-triene-3,17-dione      
Aromatase
        
7-Hydroxyflavanone      
Aromatase
        99.59%
Phortress free base
CYP1
              
PROTAC CYP1B1 degrader-2
CYP1B1, DC50: 1 nM
              
hCYP3A4-IN-1  
CYP3A4, IC50: 43.93 nM
            
Monoamine oxidase/Aromatase-IN-1      
Aromatase
        
RO6889678  
CYP3A4
            
CYP51/PD-L1-IN-4        
CYP51, IC50: 0.17 ± 0.0 μM
      
Tabimorelin hemifumarate  
CYP3A4
            
Aromatase-IN-2      
Aromatase
        99.83%
17(S)-HETE
CYP1B1
              
Licopyranocoumarin  
CYP3A4, IC50: 32 μM
            
Methysticin
CYP1A1
              
Thujopsene 
CYP2B6, IC50: 1.3 μM
CYP2C19, IC50: 13.6 μM
CYP2C8, IC50: 29.8 μM
CYP2C9, IC50: 44.9 μM
CYP3A4, IC50: 12.6 μM
            
CYP11B2-IN-2    
CYP11B2, IC50: 0.3 nM
CYP11B1, IC50: 3.8 nM
          
10-Hydroxywarfarin           
CYP2C9, IC50: 1.6 μM
   
Isolimonexic acid      
Aromatase
        
CYP1B1 ligand 3
CYP1B1, IC50: 11.9 nM
CYP1A1, IC50: 278.7 nM
CYP1A2, IC50: 3913.5 nM
              
CYP3A4-IN-4  
CYP3A4
            
Cloperidone           
CYP2C9, IC50: 17.7 μM
   
CYP51/Hsp90-IN-1        
CYP51
      
CYP4Z1-IN-2   
CYP4Z1, Ki: 2.2 μM
           
ML252 hydrochloride
CYP1A2, IC50: 6.1 μM
CYP2C9, IC50: 18.9 μM
CYP2D6, IC50: 19.9 μM
CYP3A4, IC50: 3.9 μM
            
Sorafenib N-oxide             
CYP3A4, Ki: 15 μM
 
Org30958      
Aromatase